![]() |
Volumn 27, Issue 6, 2012, Pages 658-662
|
Different truncation methods of AUC between Japan and the EU for bioequivalence assessment: Influence on the regulatory judgment
a
KEIO UNIVERSITY
(Japan)
|
Author keywords
AUC; Bioequivalence; Clinical pharmacokinetics; Drug development; Regulatory science; Sustained release formulation
|
Indexed keywords
GENERIC DRUG;
AREA UNDER THE CURVE;
BIOEQUIVALENCE;
COMPARTMENT MODEL;
CONTROLLED STUDY;
DRUG INFORMATION;
DRUG PACKAGING;
DRUG SOLUBILITY;
EUROPEAN UNION;
INTERNATIONAL COOPERATION;
JAPAN;
LIMIT OF QUANTITATION;
MAXIMUM PLASMA CONCENTRATION;
MEASUREMENT ACCURACY;
NOTE;
PLASMA CONCENTRATION-TIME CURVE;
PRACTICE GUIDELINE;
SIMULATION;
SUSTAINED RELEASE FORMULATION;
VALIDITY;
|
EID: 84871673850
PISSN: 13474367
EISSN: 18800920
Source Type: Journal
DOI: 10.2133/dmpk.DMPK-12-RG-033 Document Type: Article |
Times cited : (2)
|
References (8)
|